DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

7.54 0.29 (4.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OREX $7.54 4.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.84
Previous Close $7.25
Daily Range $7.39 - $7.87
52-Week Range $3.11 - $9.37
Market Cap $932.9M
P/E Ratio -22.66
Dividend (Yield) $0.00 (0.0%)
Volume 9,700,016
Average Daily Volume 8,427,945
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drug Makers

Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website: http://www.orexigen.com/

News & Commentary Rss Feed

Biotech Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers insight on three biotech stocks, including two that investors should stay away from.

Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog

Has Orexigen Delivered A Death Knell To Vivus?

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Arena Investors Need To Pay Attention To Competition

Oxford Industries, Orexigen And GameStop Lead Thursday's After-Hours Movers

Orexigen: Contrave Gathering Momentum

Vivus, Arena, Or Orexigen - Which Will Win The Anti-Obesity Market Share Race?

Orexigen Therapeutics (OREX) Showing Signs Of A Dead Cat Bounce Today

See More OREX News...

OREX's Top Competitors

OREX $7.54 (4.00%)
Current stock: OREX
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB